Clinical Trial Update: A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study to evaluate the safety and initial activity of BAY 3547926 in adults with advanced hepatocellular carcinoma. Recruitment is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• BAY 3547926

Snippet

Sponsor: Bayer | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING